Activation and inhibition of CTP synthase from Trypanosoma brucei, the causative agent of African sleeping sickness

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

CTP Synthase from Trypanosoma brucei (TbCTPS) catalyzes the conversion of UTP to CTP and is a recognized target for the development of antiprotozoal agents. GTP activates glutamine-dependent CTP formation catalyzed by TbCTPS at concentrations below 0.2 mM, but inhibits this activity at concentrations above 0.2 mM. TbCTPS catalyzes ammonia-dependent CTP formation, which is inhibited by purine derivatives such as GTP, guanosine, caffeine, and uric acid with IC(50) values of 460, 380, 480, and 100 μM, respectively. These observations suggest that the purine ring may serve as a useful scaffold for the development of inhibitors of trypanosomal CTP synthase.

Knowledge Graph

Similar Paper

Activation and inhibition of CTP synthase from Trypanosoma brucei, the causative agent of African sleeping sickness
Bioorganic & Medicinal Chemistry Letters 2011.0
Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids
Bioorganic & Medicinal Chemistry Letters 2010.0
Development of Potent Purine-Derived Nitrile Inhibitors of the Trypanosomal Protease TbcatB
Journal of Medicinal Chemistry 2008.0
Catechol Pyrazolinones as Trypanocidals: Fragment-Based Design, Synthesis, and Pharmacological Evaluation of Nanomolar Inhibitors of Trypanosomal Phosphodiesterase B1
Journal of Medicinal Chemistry 2012.0
Design, Synthesis, and Structure−Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents
Journal of Medicinal Chemistry 2011.0
C6–O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents
European Journal of Medicinal Chemistry 2020.0
Synthesis of a series of N6-substituted adenosines with activity against trypanosomatid parasites
European Journal of Medicinal Chemistry 2009.0
Synthesis and Structure–Activity Relationships of New Quinolone-Type Molecules against Trypanosoma brucei
Journal of Medicinal Chemistry 2012.0
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)
Bioorganic & Medicinal Chemistry 2019.0
Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors
European Journal of Medicinal Chemistry 2021.0